{"id":"NCT05584657","sponsor":"Iterum Therapeutics, International Limited","briefTitle":"Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women","officialTitle":"A Prospective, Phase 3, Randomized, Multi-center, Double-blind Study of the Efficacy, Tolerability, and Safety of Oral Sulopenem Etzadroxil/Probenecid Versus Oral Amoxicillin/Clavulanate for Treatment of Uncomplicated Urinary Tract Infections (uUTI) in Adult Women","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-10-18","primaryCompletion":"2023-11-03","completion":"2023-11-21","firstPosted":"2022-10-18","resultsPosted":"2024-11-20","lastUpdate":"2024-11-20"},"enrollment":2229,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Urinary Tract Infections","Cystitis"],"interventions":[{"type":"DRUG","name":"Sulopenem etzadroxil/probenecid","otherNames":["Oral sulopenem"]},{"type":"DRUG","name":"Amoxicillin/clavulanate","otherNames":["Augmentin"]}],"arms":[{"label":"Sulopenem etzadroxil/probenecid","type":"EXPERIMENTAL"},{"label":"Amoxicillin/clavulanate","type":"ACTIVE_COMPARATOR"}],"summary":"Study 310 is a clinical study which compares the effectiveness of oral sulopenem versus oral amoxicillin/clavulanate for the treatment of adult women with uncomplicated urinary tract infection.","primaryOutcome":{"measure":"Overall Success","timeFrame":"Day 12+/-1 day","effectByArm":[{"arm":"Sulopenem Etzadroxil/Probenecid","deltaMin":318,"sd":null},{"arm":"Amoxicillin/Clavulanate","deltaMin":260,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":12},"locations":{"siteCount":167,"countries":["United States"]},"refs":{"pmids":["40552968"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":1107},"commonTop":["Diarrhea","Nausea","Headache","Vulvovaginal mycotic infection","Vomiting"]}}